Area of research
Rheumatology · Orthopedics and Sports Medicine
Research interest
Research interests include Rheumatoid Arthritis Research and Therapies, Bone health and osteoporosis research, Osteoarthritis Treatment and Mechanisms, and Spondyloarthritis Studies and Treatments.
Expert consensus recommendations for the diagnosis and treatment of chronic non-bacterial osteitis (CNO) in adults
X-Linked Hypophosphatemia Management in Adults: An International Working Group Clinical Practice Guideline
Management of aromatase inhibitor-associated bone loss (AIBL) in women with hormone-sensitive breast cancer: An updated joint position statement of the IOF, CABS, ECTS, IEG, ESCEO, IMS, and SIOG
Transition Care for Young Persons with Rare Bone Mineral Conditions: A Consensus Recommendation from the ECTS Rare Bone Disease Action Group
Treating osteoporosis with denosumab or bisphosphonates in the long term: facts, uncertainties and assumptions. A narrative review by the clinical action group of the European Calcified Tissue Society (ECTS)
A consensus statement on the management of vertebral fractures in CKD stages G4–G5D
Impact of osteoporosis and osteoporosis medications on fracture healing: a narrative review
Prevention and treatment of glucocorticoid-induced osteoporosis in adults: recommendations from the European Calcified Tissue Society
Race-specific FRAX models are evidence-based and support equitable care: a response to the ASBMR Task Force report on Clinical Algorithms for Fracture Risk
Initial glucocorticoid bridging in rheumatoid arthritis: does it affect glucocorticoid use over time?
Alternative and complementary therapies in osteoarthritis and cartilage repair
A patient-level key performance indicator set to measure the effectiveness of fracture liaison services and guide quality improvement: a position paper of the IOF Capture the Fracture Working Group, National Osteoporosis Foundation and Fragility Fracture Network
Is a treat-to-target strategy in osteoporosis applicable in clinical practice? Consensus among a panel of European experts
Denosumab Versus Risedronate in Glucocorticoid‐Induced Osteoporosis: Final Results of a Twenty‐Four–Month Randomized, Double‐Blind, Double‐Dummy Trial
Balancing benefits and risks in the era of biologics
Patients’ preferences for osteoarthritis treatment: the value of stated-preference studies
Denosumab versus risedronate in glucocorticoid-induced osteoporosis: a multicentre, randomised, double-blind, active-controlled, double-dummy, non-inferiority study
EULAR/EFORT recommendations for management of patients older than 50 years with a fragility fracture and prevention of subsequent fractures
Systemic Inflammation Affects Human Osteocyte-Specific Protein and Cytokine Expression
Balancing benefits and risks of glucocorticoids in rheumatic diseases and other inflammatory joint disorders: new insights from emerging data. An expert consensus paper from the European Society for Clinical and Economic Aspects of Osteoporosis and Osteoarthritis (ESCEO)
Biomechanical and neuromuscular adaptations during the landing phase of a stepping-down task in patients with early or established knee osteoarthritis
CXCL8 and CCL20 Enhance Osteoclastogenesis via Modulation of Cytokine Production by Human Primary Osteoblasts
Mechanical Loading Reduces Inflammation-Induced Human Osteocyte-to-Osteoclast Communication
Bisphosphonates and glucocorticoid-induced osteoporosis: cons
OsteoRheumatology: a new discipline?
Republished: Value of biomarkers in osteoarthritis: current status and perspectives
Inflammatory factors in the circulation of patients with active rheumatoid arthritis stimulate osteoclastogenesis via endogenous cytokine production by osteoblasts
Value of biomarkers in osteoarthritis: current status and perspectives
SCOPE: a scorecard for osteoporosis in Europe
A flexed posture in elderly patients is associated with impairments in postural control during walking